GVK Biosciences Partners with Excel PharmaStudies in China

Thursday, April 16, 2009 08:04 AM

India-based contract research organization (CRO) GVK Biosciences formed a strategic alliance with Excel PharmaStudies, a CRO in China, to offer clinical trial services across India and China.

The two companies will help sponsors conduct and manage phase II to IV clinical trials, statistical analysis and medical writing. Under the terms of the agreement, any India trial for Excel will be conducted by GVK Biosciences and any China trial for GVK Biosciences will be conducted by Excel.

According to a GVK release, this is the first alliance of its kind between an Indian CRO and a Chinese one.

The Excel partnership is part of a GVK strategic plan to increase its focus on clinical development. The company recently hired Dr. Shoibal Mukherjee as head of clinical development and added new services in pharmacovigilance and medical writing.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs